Compare KSCP & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KSCP | ELUT |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 42.5M |
| IPO Year | 2022 | 2020 |
| Metric | KSCP | ELUT |
|---|---|---|
| Price | $1.23 | $0.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $17.00 | $6.00 |
| AVG Volume (30 Days) | ★ 603.6K | 50.4K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.54 | ★ 146.77 |
| EPS | N/A | ★ N/A |
| Revenue | $11,335,000.00 | ★ $12,293,000.00 |
| Revenue This Year | $218.66 | N/A |
| Revenue Next Year | $54.32 | $10.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 4.91 | N/A |
| 52 Week Low | $1.32 | $0.50 |
| 52 Week High | $7.62 | $1.39 |
| Indicator | KSCP | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 36.08 |
| Support Level | N/A | $0.51 |
| Resistance Level | $1.52 | $1.03 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 10.26 | 1.39 |
Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.